Here’s a structured FAQ for TIR1 antibody research, organized by scientific depth and methodology, based on current research findings:
Perform immunoblotting using Arabidopsis tir1-1 mutant lines as negative controls .
Use epitope mapping with synthetic peptides matching TIR1’s auxin-binding pocket (residues 170–473) to confirm antibody recognition .
Validate via co-immunoprecipitation (Co-IP) with known TIR1 interactors (e.g., ASK1 or Aux/IAA proteins) .
Quantitative Western blotting: Measure TIR1 protein levels in response to auxin treatment (10 µM IAA, 0–60 min) .
Immunolocalization: Optimize fixation protocols (4% formaldehyde, 20 min) to preserve TIR1 subcellular localization in root tips .
Pull-down assays: Identify TIR1-interacting partners using crosslinkers like DSP (dithiobis[succinimidyl propionate]) .
Generate chimeric AFB/TIR1 proteins to map antibody binding regions (e.g., LRR domain swaps) .
Use CRISPR-Cas9 knockout lines (e.g., afb1-5, afb2-3) to isolate TIR1-specific signals .
Employ competitive ELISA with recombinant AFB proteins to quantify cross-reactivity thresholds .
Treat transgenic lines (e.g., IAA7-luciferase) with 5 µM auxin.
Collect samples at 0, 2, 5, 10, 20 min post-treatment.
Use TIR1 antibody (1:1,000 dilution) for Western blotting alongside anti-luciferase antibodies .
Critical controls: Include tir1-1 mutants and auxin transport inhibitors (e.g., NPA).